Ameritas Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.96K	Buy	+143	New	+$6.96K	﹤0.01%	2144
2023 Q2	–	Sell	-300	Closed	-$14.2K	–	946
2023 Q1	$14.2K	Buy	+300	New	+$14.2K	﹤0.01%	1777